ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...

Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when drugs damage the kidneys.

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

MASH is a culmination of steatosis, inflammation, and fibrosis, and is also associated with comorbidities such as obesity and ...

The push to understand and effectively treat neurodegenerative diseases has entered a new era with the rise of artificial intelligence (AI). This ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Used as a form of status update, biomarker levels can guide when to stop antibiotics. Clinical trials examining biomarker-guided protocols have yielded inconsistent recommendations. Conflicting ...

In this roundtable, the panel highlight the adoption of biomarker strategies that can create efficiency in your clinical cell therapy development efforts ... and HLA haplotype to support translational ...